The Companies Will Offer an Integrated Device and Fill-and-Finish Solution to Streamline the Management of the Pharmaceutical Supply Chain The semi-reusable drug delivery device will provide ...

Collaboration underscores both companies’ commitment to advancing patient-centric solutions and expanding access to therapies through novel drug delivery technologies Under the terms of the agreement, ...

CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), announced ...

Though they are both multiple myeloma drugs with the same mechanism of action, Sanofi’s Sarclisa has had difficulty competing with Johnson & Johnson’s powerhouse Darzalex, largely because it reached ...

Companies in the on-body drug delivery devices market are working toward launching more efficient on-body delivery systems for injectables. They are also exploring the launch of multifunctional system ...

The SC formulation of isatuximab showed noninferiority to the IV version in the phase 3 IRAKLIA study for multiple myeloma. The study used an on-body delivery system, enhancing patient convenience and ...

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that the company has reached a definitive agreement to sell all manufacturing ...

EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced that it has entered into a definitive agreement to sell all manufacturing and supply rights for its SmartDose® 3.5mL On-Body ...